Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Puradelta Lestari Tbk. (DMAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Puradelta Lestari Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Puradelta Lestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 39.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 71K). Which is the better fit depends on your goals.

DMASOBAT
Market Cap
6.6T167.37B
Volume
40.24M71K
Lot
402.39K710
Turnover
5.52B17.51M
Average Price
137.3246.63
Value
5.52B17.51M
Indicative Equilibrium Price
137246
Indicative Equilibrium Volume
9.27K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DMAS
View details
OBAT
View details

About Puradelta Lestari Tbk.

PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.

Read more on DMAS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT